FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Pierre Marquet

Research Profile

Chemicals & Drugs

Concepts & Ideas

Procedures

Occupations

Forensic Medicine

Co-author Network

Publications

TOP 3
Z Daher Abdi; M Essig; Y Le Meur; Pierre Marquet; Aurélie Prémaud; Jean-Philippe Rérolle; D Rizopoulos; J B Woillard; Annick Rousseau
Impact of longitudinal exposure to mycophenolic acid on acute rejection in renal-transplant recipients using a joint modeling approach.
Florent Di Meo; Jean-Luc Duroux; Pierre Marquet; Picard Nicolas; Michele Steel; Patrick Trouillas
Acylglucuronide in alkaline conditions: migration vs. hydrolysis.
Dorothée Fruit; Nassim Kamar; Pierre Marquet; Michel Redonnet; Florence Rollé; Annick Rousseau; Laurent Sebbag; Catherine Amrein; ERIC EPAILLY; Aurélie Prémaud
Ciclosporin population pharmacokinetics and Bayesian estimation in thoracic transplant recipients.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Pierre Marquet (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Z Daher Abdi; M Essig; Y Le Meur; Pierre Marquet; Aurélie Prémaud; Jean-Philippe Rérolle; D Rizopoulos; J B Woillard; Annick Rousseau
Impact of longitudinal exposure to mycophenolic acid on acute rejection in renal-transplant recipients using a joint modeling approach.
Pharmacological research : the official journal of the Italian Pharmacological Society 2013;72():52-60.
2013: Florent Di Meo; Jean-Luc Duroux; Pierre Marquet; Picard Nicolas; Michele Steel; Patrick Trouillas
Acylglucuronide in alkaline conditions: migration vs. hydrolysis.
Journal of molecular modeling 2013;19(6):2423-32.
2013: Dorothée Fruit; Nassim Kamar; Pierre Marquet; Michel Redonnet; Florence Rollé; Annick Rousseau; Laurent Sebbag; Catherine Amrein; ERIC EPAILLY; Aurélie Prémaud
Ciclosporin population pharmacokinetics and Bayesian estimation in thoracic transplant recipients.
Clinical pharmacokinetics 2013;52(4):277-88.
2013: Alaa Al Saabi; Delphine Allorge; Jean-Michel Gaulier; Pierre Marquet; François-Ludovic Sauvage; Gilles Tournel; Nicolas Picard
Involvement of UDP-glucuronosyltransferases UGT1A9 and UGT2B7 in ethanol glucuronidation, and interactions with common drugs of abuse.
Drug metabolism and disposition: the biological fate of chemicals 2013;41(3):568-74.
2012: François-Ludovic Sauvage; Louis Noël Gastinel; Pierre Marquet
Untargeted screening of urinary peptides with liquid chromatography coupled to hybrid linear-ion trap tandem mass spectrometry.
Journal of chromatography. A 2012;1259():138-47.
2012: Jean-Baptiste Woillard; Nassim Kamar; Pierre Marquet; Lionel Rostaing; Annick Rousseau; Nicolas Picard
Association of sirolimus adverse effects with m-TOR, p70S6K or Raptor polymorphisms in kidney transplant recipients.
Pharmacogenetics and genomics 2012;22(10):725-32.
2012: Anne-Laure Gagez; Pierre Marquet; Koukeb Rouguieg-Malki; François-Ludovic Sauvage; Nicolas Picard
Simultaneous evaluation of six human glucuronidation activities in liver microsomes using liquid chromatography-tandem mass spectrometry.
Analytical biochemistry 2012;427(1):52-9.
2012: Fabien Lamoureux; Nicolas Picard; François-Ludovic Sauvage; Belkacem Boussera; Pierre Marquet
Sirolimus and everolimus intestinal absorption and interaction with calcineurin inhibitors: a differential effect between cyclosporine and tacrolimus.
Fundamental & clinical pharmacology 2012;26(4):463-72.
2012: Caroline Monchaud; Christophe Pison; Martine Reynaud-Gaubert; Brenda C de Winter; Marc Estenne; Romain Guillemain; Romain Kessler; Christiane Knoop; Pierre Marquet; Marc Stern; Annick Rousseau
Population pharmacokinetic modelling and design of a Bayesian estimator for therapeutic drug monitoring of tacrolimus in lung transplantation.
Clinical pharmacokinetics 2012;51(3):175-86.
2012: François-Ludovic Sauvage; Pierre Marquet
LC-MS/MS screen for xenobiotics and metabolites.
Methods in molecular biology (Clifton, N.J.) 2012;902():129-38.
2012: Pierre Marquet
LC-MS vs. GC-MS, online extraction systems, advantages of technology for drug screening assays.
Methods in molecular biology (Clifton, N.J.) 2012;902():15-27.
2011: F Lamoureux; Pierre Marquet; E Mestre; François-Ludovic Sauvage; M Essig; L N Gastinel
Quantitative proteomic analysis of cyclosporine-induced toxicity in a human kidney cell line and comparison with tacrolimus.
Journal of proteomics 2011;75(2):677-94.
2011: Véronique Loustaud-Ratti; Pierre Marquet; Marianne Maynard; Alexandrina Pinta; Stanislas Pol; Annick Rousseau; Denis Sautereau; Christian Trépo; Jean-Pierre Zarski; Sophie Alain; Gérard Babany; Marc Bourlière; Paul Carrier; Victor de Ledinghen; Vincent Di Martino
Pharmacological exposure to ribavirin: a key player in the complex network of factors implicated in virological response and anaemia in hepatitis C treatment.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2011;43(11):850-5.
2011: Franck Saint-Marcoux; Soizic Vandierdonck; Aurélie Prémaud; Jean Debord; Annick Rousseau; Pierre Marquet
Large scale analysis of routine dose adjustments of mycophenolate mofetil based on global exposure in renal transplant patients.
Therapeutic drug monitoring 2011;33(3):285-94.
2011: Aurélie Prémaud; Annick Rousseau; Gyasi Johnson; Cindy Canivet; Peggy Gandia; Fabrice Muscari; Jean Marie Peron; Lionel Rostaing; Pierre Marquet; Nassim Kamar
Inhibition of T-cell activation and proliferation by mycophenolic acid in patients awaiting liver transplantation: PK/PD relationships.
Pharmacological research : the official journal of the Italian Pharmacological Society 2011;63(5):432-8.
2011: Franck Saint-Marcoux; Jean Debord; François Parant; Myriam Labalette; Nassim Kamar; Lionel Rostaing; Annick Rousseau; Pierre Marquet
Development and evaluation of a simulation procedure to take into account various assays for the Bayesian dose adjustment of tacrolimus.
Therapeutic drug monitoring 2011;33(2):171-7.
2010: Noël Zahr; Laurent Arnaud; Pierre Marquet; Julien Haroche; Nathalie Costedoat-Chalumeau; Jean-Sébastien Hulot; Christian Funck-Brentano; Jean-Charles Piette; Zahir Amoura
Mycophenolic acid area under the curve correlates with disease activity in lupus patients treated with mycophenolate mofetil.
Arthritis and rheumatism 2010;62(7):2047-54.
2010: Jean-Baptiste Woillard; Jean-Philippe Rerolle; Nicolas Picard; Annick Rousseau; Mireille Drouet; Eliza Munteanu; Marie Essig; Pierre Marquet; Yann Le Meur
Risk of diarrhoea in a long-term cohort of renal transplant patients given mycophenolate mofetil: the significant role of the UGT1A8 2 variant allele.
British journal of clinical pharmacology 2010;69(6):675-83.
2010: Annick Rousseau; Marie-Laure Laroche; Nicolas Venisse; Cecile Loichot-Roselmac; Alain Turcant; Guillaume Hoizey; Patricia Compagnon; Lionel Hary; Danièle Debruyne; Sylvie Saivin; Evelyne Jacqz-Aigrain; Mathias Buchler; Claire Villeneuve; Alain Vergnenègre; Yannick Le Meur; Pierre Marquet
Cost-effectiveness analysis of individualized mycophenolate mofetil dosing in kidney transplant patients in the APOMYGRE trial.
Transplantation 2010;89(10):1255-62.
2010: Pierre Marquet; François-Ludovic Sauvage; Véronique Loustaud-Ratti; Gérard Babany; Annick Rousseau; Gérard Lachâtre
Stability of ribavirin concentrations depending on the type of blood collection tube and preanalytical conditions.
Therapeutic drug monitoring 2010;32(2):237-41.
2010: Franck Saint-Marcoux; Jean Debord; Nasrullah Undre; Annick Rousseau; Pierre Marquet
Pharmacokinetic modeling and development of Bayesian estimators in kidney transplant patients receiving the tacrolimus once-daily formulation.
Therapeutic drug monitoring 2010;32(2):129-35.
2010: Sylvain Dulaurent; Christian Moesch; Pierre Marquet; Jean-Michel Gaulier; Gérard Lachâtre
Screening of pesticides in blood with liquid chromatography-linear ion trap mass spectrometry.
Analytical and bioanalytical chemistry 2010;396(6):2235-49.
2010: François-Ludovic Sauvage; Pierre Marquet
ESI-MS-MS library of 1,253 compounds for application in forensic and clinical toxicology.
Analytical and bioanalytical chemistry 2010;396(5):1947.
2010: Lionel Rostaing; Olivier Cointault; Pierre Marquet; Anne-Gaelle Josse; Michel Lavit; Franck Saint-Marcoux; Nassim Kamar
Falsely elevated whole-blood tacrolimus concentrations in a kidney-transplant patient: potential hazards.
Transplant international : official journal of the European Society for Organ Transplantation 2010;23(2):227-30.
2010: Koukeb Rouguieg; Nicolas Picard; François-Ludovic Sauvage; Jean-Michel Gaulier; Pierre Marquet
Contribution of the different UDP-glucuronosyltransferase (UGT) isoforms to buprenorphine and norbuprenorphine metabolism and relationship with the main UGT polymorphisms in a bank of human liver microsomes.
Drug metabolism and disposition: the biological fate of chemicals 2010;38(1):40-5.
2009: François-Ludovic Sauvage; Nicolas Picard; Franck Saint-Marcoux; Jean-Michel Gaulier; Gérard Lachâtre; Pierre Marquet
General unknown screening procedure for the characterization of human drug metabolites in forensic toxicology: applications and constraints.
Journal of separation science 2009;32(18):3074-83.
2009: Pierre Marquet; Franck Saint-Marcoux; Aurélie Prémaud; François-Ludovic Sauvage; Evelyne Jaqz-Aigrain; Christiane Knoop; Yvon Lebranchu; Marco Tiberi; Ingrid Domke; Jean Debord
Performance of the new mycophenolate assay based on IMPDH enzymatic activity for pharmacokinetic investigations and setup of Bayesian estimators in different populations of allograft recipients.
Therapeutic drug monitoring 2009;31(4):443-50.
2009: Nassim Kamar; Pierre Marquet; Peggy Gandia; Fabrice Muscari; Laurence Lavayssière; Laure Esposito; Joelle Guitard; Cindy Canivet; Jean Marie Peron; Laurent Alric; Bertrand Suc; Franck Saint-Marcoux; Lionel Rostaing
Mycophenolic acid 12-hour area under the curve in de novo liver transplant patients given mycophenolate mofetil at fixed versus concentration-controlled doses.
Therapeutic drug monitoring 2009;31(4):451-6.
2009: Nicolas Picard; Dorra Dridi; François-Ludovic Sauvage; Naceur A Boughattas; Pierre Marquet
General unknown screening procedure for the characterization of human drug metabolites: Application to loratadine phase I metabolism.
Journal of separation science 2009;32(13):2209-17.
2009: Khaled Benkali; Aurélie Prémaud; Nicolas Picard; Jean-Philippe Rérolle; Olivier Toupance; Guillaume Hoizey; Alain Turcant; Florence Villemain; Yann Le Meur; Pierre Marquet; Annick Rousseau
Tacrolimus population pharmacokinetic-pharmacogenetic analysis and Bayesian estimation in renal transplant recipients.
Clinical pharmacokinetics 2009;48(12):805-16.
2009: Franck Saint-Marcoux; Bernard Royer; Jean Debord; Fabrice Larosa; Faezeh Legrand; Eric Deconinck; Jean-Pierre Kantelip; Pierre Marquet
Pharmacokinetic modelling and development of Bayesian estimators for therapeutic drug monitoring of mycophenolate mofetil in reduced-intensity haematopoietic stem cell transplantation.
Clinical pharmacokinetics 2009;48(10):667-75.
2008: François-Ludovic Sauvage; Jean-Michel Gaulier; Gérard Lachâtre; Pierre Marquet
Pitfalls and prevention strategies for liquid chromatography-tandem mass spectrometry in the selected reaction-monitoring mode for drug analysis.
Clinical chemistry 2008;54(9):1519-27.
2008: Jean-Michel Gaulier; François-Ludovic Sauvage; Hélène Pauthier; Franck Saint-Marcoux; Pierre Marquet; Gérard Lachâtre
Identification of acepromazine in hair: an illustration of the difficulties encountered in investigating drug-facilitated crimes.
Journal of forensic sciences 2008;53(3):755-9.
2008: Véronique Loustaud-Ratti; Sophie Alain; Annick Rousseau; Isabelle Fouchard Hubert; François-Ludovic Sauvage; Pierre Marquet; François Denis; Françoise Lunel; Paul Calès; Annie Lefebvre; Anne-Laure Fauchais; Eric Liozon; Elisabeth Vidal
Ribavirin exposure after the first dose is predictive of sustained virological response in chronic hepatitis C.
Hepatology (Baltimore, Md.) 2008;47(5):1453-61.
2008: Noël Zahr; Zahir Amoura; Jean Debord; Jean-Sébastien Hulot; Franck Saint-Marcoux; Pierre Marquet; Jean Charles Piette; Philippe Lechat
Pharmacokinetic study of mycophenolate mofetil in patients with systemic lupus erythematosus and design of Bayesian estimator using limited sampling strategies.
Clinical pharmacokinetics 2008;47(4):277-84.
2007: Pierre Marquet; Nassim Djebli; Nicolas Picard
[Pharmacogenetics and immunosuppressor drugs: impact and clinical interest in transplantation].
Annales pharmaceutiques françaises 2007;65(6):382-9.
2007: Yann Le Meur; Matthias Büchler; Antoine Thierry; Sophie Caillard; Florence Villemain; Sylvie Lavaud; Isabelle Etienne; Pierre François Westeel; B Hurault de Ligny; Lionel Rostaing; Eric Thervet; Jean-Christophe Szelag; Jean-Philippe Rérolle; Annick Rousseau; guy touchard; Pierre Marquet
Individualized mycophenolate mofetil dosing based on drug exposure significantly improves patient outcomes after renal transplantation.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2007;7(11):2496-503.
2007: Franck Saint-Marcoux; François-Ludovic Sauvage; Pierre Marquet
Current role of LC-MS in therapeutic drug monitoring.
Analytical and bioanalytical chemistry 2007;388(7):1327-49.
2007: Nassim Djebli; Nicolas Picard; Jean-Philippe Rérolle; Yann Le Meur; Pierre Marquet
Influence of the UGT2B7 promoter region and exon 2 polymorphisms and comedications on Acyl-MPAG production in vitro and in adult renal transplant patients.
Pharmacogenetics and genomics 2007;17(5):321-30.
2007: Nicolas Picard; Nassim Djebli; François-Ludovic Sauvage; Pierre Marquet
Metabolism of sirolimus in the presence or absence of cyclosporine by genotyped human liver microsomes and recombinant cytochromes P450 3A4 and 3A5.
Drug metabolism and disposition: the biological fate of chemicals 2007;35(3):350-5.
2007: S Irtan; Franck Saint-Marcoux; Annick Rousseau; Daolun Zhang; valerie leroy; Pierre Marquet; Evelyne Jacqz-Aigrain
Population pharmacokinetics and bayesian estimator of cyclosporine in pediatric renal transplant patients.
Therapeutic drug monitoring 2007;29(1):96-102.
2006: Nicolas Picard; Aurélie Prémaud; Annick Rousseau; Yann Le Meur; Pierre Marquet
A comparison of the effect of ciclosporin and sirolimus on the pharmokinetics of mycophenolate in renal transplant patients.
British journal of clinical pharmacology 2006;62(4):477-84.
2006: François-Ludovic Sauvage; Franck Saint-Marcoux; Bénédicte Duretz; Didier Deporte; Gérard Lachatre; Pierre Marquet
Screening of drugs and toxic compounds with liquid chromatography-linear ion trap tandem mass spectrometry.
Clinical chemistry 2006;52(9):1735-42.
2006: Yann Le Meur; Nassim Djebli; Jean-Christophe Szelag; Guillaume Hoizey; Olivier Toupance; Jean-Philippe Rérolle; Pierre Marquet
CYP3A5*3 influences sirolimus oral clearance in de novo and stable renal transplant recipients.
Clinical pharmacology and therapeutics 2006;80(1):51-60.
2006: Oscar Quintela; François-Ludovic Sauvage; Fabienne Charvier; Jean-Michel Gaulier; Gérard Lachâtre; Pierre Marquet
Liquid chromatography-tandem mass spectrometry for detection of low concentrations of 21 benzodiazepines, metabolites, and analogs in urine: method with forensic applications.
Clinical chemistry 2006;52(7):1346-55.
2006: Aurélie Prémaud; Annick Rousseau; Nicolas Picard; Pierre Marquet
Determination of mycophenolic acid plasma levels in renal transplant recipients co-administered sirolimus: comparison of an enzyme multiplied immunoassay technique (EMIT) and liquid chromatography-tandem mass spectrometry.
Therapeutic drug monitoring 2006;28(2):274-7.
2006: S Dulaurent; Franck Saint-Marcoux; Pierre Marquet; Gérard Lachâtre
Simultaneous determination of six dialkylphosphates in urine by liquid chromatography tandem mass spectrometry.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2006;831(1-2):223-9.
2006: Franck Saint-Marcoux; Pierre Marquet; Annick Rousseau
Population pharmacokinetics of cyclosporine in cardiopulmonary transplant recipients.
Therapeutic drug monitoring 2006;28(1):138; author reply 139.
2006: François-Ludovic Sauvage; Jean-Michel Gaulier; Gérard Lachâtre; Pierre Marquet
A fully automated turbulent-flow liquid chromatography-tandem mass spectrometry technique for monitoring antidepressants in human serum.
Therapeutic drug monitoring 2006;28(1):123-30.
2006: Nassim Djebli; Annick Rousseau; Guillaume Hoizey; Jean-Philippe Rerolle; Olivier Toupance; Yann Le Meur; Pierre Marquet
Sirolimus population pharmacokinetic/pharmacogenetic analysis and bayesian modelling in kidney transplant recipients.
Clinical pharmacokinetics 2006;45(11):1135-48.
2006: Franck Saint-Marcoux; Pierre Marquet; Evelyne Jacqz-Aigrain; Nicole Bernard; Philippe Thiry; Yann Le Meur; Annick Rousseau
Patient characteristics influencing ciclosporin pharmacokinetics and accurate Bayesian estimation of ciclosporin exposure in heart, lung and kidney transplant patients.
Clinical pharmacokinetics 2006;45(9):905-22.
2005: Pierre Marquet
Clinical application of population pharmacokinetic methods developed for immunosuppressive drugs.
Therapeutic drug monitoring 2005;27(6):727-32.
2005: Matthias Büchler; Yvon Lebranchu; Maud Bénéton; Yann Le Meur; Anne Elisabeth Heng; Pierre François Westeel; Chantal Le Guellec; Frédéric Libert; Lionel Hary; Pierre Marquet; Gilles Paintaud
Higher exposure to mycophenolic acid with sirolimus than with cyclosporine cotreatment.
Clinical pharmacology and therapeutics 2005;78(1):34-42.
2005: Aurélie Prémaud; Yann Le Meur; Jean Debord; Jean-Christophe Szelag; Annick Rousseau; Guillaume Hoizey; Olivier Toupance; Pierre Marquet
Maximum a posteriori bayesian estimation of mycophenolic acid pharmacokinetics in renal transplant recipients at different postgrafting periods.
Therapeutic drug monitoring 2005;27(3):354-61.
2005: Christiane Knoop; Philippe Thiry; Franck Saint-Marcoux; Annick Rousseau; Pierre Marquet; Marc Estenne
Tacrolimus pharmacokinetics and dose monitoring after lung transplantation for cystic fibrosis and other conditions.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2005;5(6):1477-82.
2005: Nicolas Picard; Thierry CRESTEIL; Nassim Djebli; Pierre Marquet
In vitro metabolism study of buprenorphine: evidence for new metabolic pathways.
Drug metabolism and disposition: the biological fate of chemicals 2005;33(5):689-95.
2005: Robert Jansen; Gérard Lachatre; Pierre Marquet
LC-MS/MS systematic toxicological analysis: comparison of MS/MS spectra obtained with different instruments and settings.
Clinical biochemistry 2005;38(4):362-72.
2005: Franck Saint-Marcoux; Christiane Knoop; Jean Debord; Philippe Thiry; Annick Rousseau; Marc Estenne; Pierre Marquet
Pharmacokinetic study of tacrolimus in cystic fibrosis and non-cystic fibrosis lung transplant patients and design of Bayesian estimators using limited sampling strategies.
Clinical pharmacokinetics 2005;44(12):1317-28.
2005: Aurélie Prémaud; Jean Debord; Annick Rousseau; Yann Le Meur; Olivier Toupance; Yvon Lebranchu; Guillaume Hoizey; Chantal Le Guellec; Pierre Marquet
A double absorption-phase model adequately describes mycophenolic acid plasma profiles in de novo renal transplant recipients given oral mycophenolate mofetil.
Clinical pharmacokinetics 2005;44(8):837-47.
2005: Nicolas Picard; Damrong Ratanasavanh; Aurélie Prémaud; Yann Le Meur; Pierre Marquet
Identification of the UDP-glucuronosyltransferase isoforms involved in mycophenolic acid phase II metabolism.
Drug metabolism and disposition: the biological fate of chemicals 2005;33(1):139-46.
2004: Aurélie Prémaud; Annick Rousseau; Yann Le Meur; Gérard Lachâtre; Pierre Marquet
Comparison of liquid chromatography-tandem mass spectrometry with a commercial enzyme-multiplied immunoassay for the determination of plasma MPA in renal transplant recipients and consequences for therapeutic drug monitoring.
Therapeutic drug monitoring 2004;26(6):609-19.
2004: Nicolas Picard; Thierry CRESTEIL; Aurélie Prémaud; Pierre Marquet
Characterization of a phase 1 metabolite of mycophenolic acid produced by CYP3A4/5.
Therapeutic drug monitoring 2004;26(6):600-8.
2004: Dany Anglicheau; Eric Thervet; Isabelle Etienne; Bruno Hurault de Ligny; Yann Le Meur; guy touchard; Matthias Büchler; Pierre Laurent-Puig; David-Alexandre Tregouet; Philippe Beaune; Ann Daly; Christophe Legendre; Pierre Marquet
CYP3A5 and MDR1 genetic polymorphisms and cyclosporine pharmacokinetics after renal transplantation.
Clinical pharmacology and therapeutics 2004;75(5):422-33.
2004: Hervé Sayer; Oscar Quintela; Pierre Marquet; Jean-Louis Dupuy; Jean-Michel Gaulier; Gérard Lachâtre
Identification and quantitation of six non-depolarizing neuromuscular blocking agents by LC-MS in biological fluids.
Journal of analytical toxicology 2004;28(2):105-10.
2004: Annick Rousseau; F Léger; Yann Le Meur; Franck Saint-Marcoux; Gilles Paintaud; M Buchler; Pierre Marquet
Population pharmacokinetic modeling of oral cyclosporin using NONMEM: comparison of absorption pharmacokinetic models and design of a Bayesian estimator.
Therapeutic drug monitoring 2004;26(1):23-30.
2004: Jean-Michel Gaulier; Fabienne Charvier; Françoise Monceaux; Pierre Marquet; Gérard Lachatre
Ingestion of high-dose buprenorphine by a 4 year-old child.
Journal of toxicology. Clinical toxicology 2004;42(7):993-5.
2004: Annick Rousseau; Pierre Marquet
Modelling ciclosporin double-peak absorption profiles in the early post-transplantation period.
Clinical pharmacokinetics 2004;43(14):1055-7.
2003: Christiane Knoop; Ingrid Vervier; Philippe Thiry; Marc De Backer; John M Kovarik; Annick Rousseau; Pierre Marquet; Marc Estenne
Cyclosporine pharmacokinetics and dose monitoring after lung transplantation: comparison between cystic fibrosis and other conditions.
Transplantation 2003;76(4):683-8.
2003: Jean-Michel Gaulier; Véronique Tonnay; Thierry Faict; Hervé Sayer; Pierre Marquet; Gérard Lachâtre
Analytical aspects of volatile substance abuse (VSA).
Journal of forensic sciences 2003;48(4):880-2.
2003: Pierre Marquet; Franck Saint-Marcoux; T N Gamble; J C Y Leblanc
Comparison of a preliminary procedure for the general unknown screening of drugs and toxic compounds using a quadrupole-linear ion-trap mass spectrometer with a liquid chromatography-mass spectrometry reference technique.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2003;789(1):9-18.
2003: Franck Saint-Marcoux; Annick Rousseau; Yann Le Meur; Marc Estenne; Christiane Knoop; Jean Debord; Pierre Marquet
Influence of sampling-time error on cyclosporine measurements nominally at 2 hours after administration.
Clinical chemistry 2003;49(5):813-5.
2003: C Monchaud; A Rousseau; F Leger; O J David; Jean Debord; Thierry Dantoine; Pierre Marquet
Limited sampling strategies using Bayesian estimation or multilinear regression for cyclosporin AUC(0-12) monitoring in cardiac transplant recipients over the first year post-transplantation.
European journal of clinical pharmacology 2003;58(12):813-20.
2003: Annick Rousseau; C Monchaud; Jean Debord; I Vervier; M Estenne; Philippe Thiry; Pierre Marquet
Bayesian forecasting of oral cyclosporin pharmacokinetics in stable lung transplant recipients with and without cystic fibrosis.
Therapeutic drug monitoring 2003;25(1):28-35.
2003: N Venisse; Pierre Marquet; E Duchoslav; Jean-Louis Dupuy; Gérard Lachâtre
A general unknown screening procedure for drugs and toxic compounds in serum using liquid chromatography-electrospray-single quadrupole mass spectrometry.
Journal of analytical toxicology 2003;27(1):7-14.
2003: Franck Saint-Marcoux; Gérard Lachâtre; Pierre Marquet
Evaluation of an improved general unknown screening procedure using liquid chromatography-electrospray-mass spectrometry by comparison with gas chromatography and high-performance liquid-chromatography--diode array detection.
Journal of the American Society for Mass Spectrometry 2003;14(1):14-22.
2002: Aurélie Prémaud; Annick Rousseau; Mireille Gicquel; Sylvie Ragot; Jacqueline Manceau; Michel Laurentie; Pierre Marquet
An animal model for the study of chronopharmacokinetics of drugs and application to methotrexate and vinorelbine.
Toxicology and applied pharmacology 2002;183(3):189-97.
2002: Annick Rousseau; Pierre Marquet
Application of pharmacokinetic modelling to the routine therapeutic drug monitoring of anticancer drugs.
Fundamental & clinical pharmacology 2002;16(4):253-62.
2002: Pierre Marquet
Progress of liquid chromatography-mass spectrometry in clinical and forensic toxicology.
Therapeutic drug monitoring 2002;24(2):255-76.
2002: Pierre Marquet
Is LC-MS suitable for a comprehensive screening of drugs and poisons in clinical toxicology?
Therapeutic drug monitoring 2002;24(1):125-33.
2002: Annick Rousseau; Christophe Sabot; Nicole Delepine; Gerard Delepine; Jean Debord; Gérard Lachâtre; Pierre Marquet
Bayesian estimation of methotrexate pharmacokinetic parameters and area under the curve in children and young adults with localised osteosarcoma.
Clinical pharmacokinetics 2002;41(13):1095-104.
2001: Jean-Michel Gaulier; G Merle; Eric Lacassie; Bruno Courtiade; Patrick Haglund; Pierre Marquet; Gérard Lachâtre
Fatal intoxications with chloral hydrate.
Journal of forensic sciences 2001;46(6):1507-9.
2001: Eric Lacassie; Pierre Marquet; Jean-Michel Gaulier; MF Dreyfuss; Gérard Lachâtre
Sensitive and specific multiresidue methods for the determination of pesticides of various classes in clinical and forensic toxicology.
Forensic science international 2001;121(1-2):116-25.
2001: Eric Lacassie; MF Dreyfuss; Jean-Michel Gaulier; Pierre Marquet; JL Daguet; Gérard Lachâtre
Multiresidue determination method for organophosphorus pesticides in serum and whole blood by gas chromatography-mass-selective detection.
Journal of chromatography. B, Biomedical sciences and applications 2001;759(1):109-16.
2001: Sylvie Ragot; F L Sauvage; Annick Rousseau; Dominique Genet; Jean-Louis Dupuy; Nicole Tubiana-Mathieu; Pierre Marquet
Sensitive determination of vinorelbine and its metabolites in human serum using liquid chromatography-electrospray mass spectrometry.
Journal of chromatography. B, Biomedical sciences and applications 2001;753(2):167-78.
2000: Jean-Michel Gaulier; Pierre Marquet; Eric Lacassie; R Desroches; Gérard Lachatre
High-performance liquid chromatographic determination of tianeptine in plasma applied to pharmacokinetic studies.
Journal of chromatography. B, Biomedical sciences and applications 2000;748(2):407-14.
2000: Eric Lacassie; Pierre Marquet; S Martin-Dupont; Jean-Michel Gaulier; Gérard Lachâtre
A non-fatal case of intoxication with foxglove, documented by means of liquid chromatography-electrospray-mass spectrometry.
Journal of forensic sciences 2000;45(5):1154-8.
2000: Eric Lacassie; Jean-Michel Gaulier; Pierre Marquet; J F Rabatel; Gérard Lachâtre
Methods for the determination of seven selective serotonin reuptake inhibitors and three active metabolites in human serum using high-performance liquid chromatography and gas chromatography.
Journal of chromatography. B, Biomedical sciences and applications 2000;742(2):229-38.
2000: Annick Rousseau; Pierre Marquet; Jean Debord; Christophe Sabot; Gérard Lachâtre
Adaptive control methods for the dose individualisation of anticancer agents.
Clinical pharmacokinetics 2000;38(4):315-53.
2000: F Lachâtre; Pierre Marquet; Sylvie Ragot; Jean-Michel Gaulier; P Cardot; Jean-Louis Dupuy
Simultaneous determination of four anthracyclines and three metabolites in human serum by liquid chromatography-electrospray mass spectrometry.
Journal of chromatography. B, Biomedical sciences and applications 2000;738(2):281-91.
2000: Jean-Michel Gaulier; Pierre Marquet; Eric Lacassie; Jean-Louis Dupuy; Gérard Lachatre
Fatal intoxication following self-administration of a massive dose of buprenorphine.
Journal of forensic sciences 2000;45(1):226-8.
1999: Sylvie Ragot; Pierre Marquet; F Lachâtre; Annick Rousseau; Eric Lacassie; Jean-Michel Gaulier; Jean-Louis Dupuy; Gérard Lachâtre
Sensitive determination of irinotecan (CPT-11) and its active metabolite SN-38 in human serum using liquid chromatography-electrospray mass spectrometry.
Journal of chromatography. B, Biomedical sciences and applications 1999;736(1-2):175-84.
1999: Pierre Marquet; O Baudin; Jean-Michel Gaulier; Eric Lacassie; Jean-Louis Dupuy; B François; Gérard Lachâtre
Sensitive and specific determination of midazolam and 1-hydroxymidazolam in human serum by liquid chromatography-electrospray mass spectrometry.
Journal of chromatography. B, Biomedical sciences and applications 1999;734(1):137-44.
1999: Pierre Marquet; Gérard Lachâtre
Liquid chromatography-mass spectrometry: potential in forensic and clinical toxicology.
Journal of chromatography. B, Biomedical sciences and applications 1999;733(1-2):93-118.
1999: MF Sauvage; Annick Rousseau; Pierre Marquet; F Dumeirain; C Raby; Gérard Lachâtre
In vitro and in vivo study of the antithyroid side effects of trimeprazine.
Toxicology and applied pharmacology 1999;158(2):125-31.
1999: G Lac; Pierre Marquet; A P Chassain; F X Galen
Dexamethasone in resting and exercising men. II. Effects on adrenocortical hormones.
Journal of applied physiology (Bethesda, Md. : 1985) 1999;87(1):183-8.
1999: Pierre Marquet; G Lac; A P Chassain; G Habrioux; F X Galen
Dexamethasone in resting and exercising men. I. Effects on bioenergetics, minerals, and related hormones.
Journal of applied physiology (Bethesda, Md. : 1985) 1999;87(1):175-82.
1999: Eric Lacassie; MF Dreyfuss; JL Daguet; M Vignaud; Pierre Marquet; Gérard Lachâtre
Liquid chromatography-electrospray mass spectrometry multi-residue determination of pesticides in apples and pears.
Journal of chromatography. A 1999;830(1):135-43.
1999: Eric Lacassie; Sylvie Ragot; Jean-Michel Gaulier; Pierre Marquet; G Lâchatre
[A specific dosage method for the analysis of 24 antidepressants using gas chromatography-mass spectrometry (GC/SM)].
Acta clinica Belgica. Supplementum 1999;1():20-4.
1998: Annick Rousseau; Pierre Marquet; JF Lagorce; MF Sauvage; J Buxeraud; Gérard Lachâtre; C Raby
Thyroid accumulation and adverse effects of imipramine and desipramine in rats after long-term administration.
Pharmacology 1998;57(5):242-8.
1998: Eric Lacassie; MF Dreyfuss; JL Daguet; M Vignaud; Pierre Marquet; Gérard Lachâtre
Multiresidue determination of pesticides in apples and pears by gas chromatography-mass spectrometry.
Journal of chromatography. A 1998;805(1-2):319-26.
1998: Christophe Sabot; Pierre Marquet; Jean Debord; N Carpentier; Louis Merle; Gérard Lachâtre
Bayesian pharmacokinetic estimation of vinorelbine in non-small-cell lung cancer patients.
European journal of clinical pharmacology 1998;54(2):171-5.
1998: Jean Debord; N Carpentier; Christophe Sabot; Philippe Bertin; Pierre Marquet; Richard Treves; Louis Merle; Gérard Lachâtre
Influence of biological variables upon pharmacokinetic parameters of intramuscular methotrexate in rheumatoid arthritis.
International journal of clinical pharmacology and therapeutics 1998;36(4):227-30.
1998: MF Sauvage; Pierre Marquet; Annick Rousseau; C Raby; J Buxeraud; Gérard Lachâtre
Relationship between psychotropic drugs and thyroid function: a review.
Toxicology and applied pharmacology 1998;149(2):127-35.
1998: C Battu; Pierre Marquet; A L Fauconnet; Eric Lacassie; Gérard Lachâtre
Screening procedure for 21 amphetamine-related compounds in urine using solid-phase microextraction and gas chromatography-mass spectrometry.
Journal of chromatographic science 1998;36(1):1-7.
1997: Pierre Marquet; J Chevrel; P Lavignasse; Louis Merle; Gérard Lachâtre
Buprenorphine withdrawal syndrome in a newborn.
Clinical pharmacology and therapeutics 1997;62(5):569-71.
1997: Pierre Marquet; Eric Lacassie; C Battu; H Faubert; Gérard Lachâtre
Simultaneous determination of amphetamine and its analogs in human whole blood by gas chromatography-mass spectrometry.
Journal of chromatography. B, Biomedical sciences and applications 1997;700(1-2):77-82.
1997: Annick Rousseau; Pierre Marquet; F Comby; J Buxeraud; C Raby; Gérard Lachâtre
Sensitive microanalysis of imipramine and desipramine in single rat thyroids by gas chromatography-mass spectrometry.
Journal of chromatography. B, Biomedical sciences and applications 1997;693(1):93-100.
1997: H Hoja; Pierre Marquet; B Verneuil; H Lotfi; Jean-Louis Dupuy; Gérard Lachâtre
Determination of LSD and N-demethyl-LSD in urine by liquid chromatography coupled to electrospray ionization mass spectrometry.
Journal of chromatography. B, Biomedical sciences and applications 1997;692(2):329-35.
1997: Pierre Marquet; B François; H Lotfi; A Turcant; Jean Debord; G Nedelec; Gérard Lachâtre
Tungsten determination in biological fluids, hair and nails by plasma emission spectrometry in a case of severe acute intoxication in man.
Journal of forensic sciences 1997;42(3):527-30.
1997: H Lotfi; Jean Debord; MF Dreyfuss; Pierre Marquet; M Ben Rhaiem; P Feiss; Gérard Lachâtre
Simultaneous determination of lidocaine and bupivacaine in human plasma: application to pharmacokinetics.
Therapeutic drug monitoring 1997;19(2):160-4.
1997: H Hoja; Pierre Marquet; B Verneuil; H Lotfi; Jean-Louis Dupuy; Gérard Lachâtre
Determination of buprenorphine and norbuprenorphine in whole blood by liquid chromatography-mass spectrometry.
Journal of analytical toxicology 1997;21(2):160-5.
1997: H Hoja; Pierre Marquet; B Verneuil; H Lotfi; B Pénicaut; Gérard Lachâtre
Applications of liquid chromatography--mass spectrometry in analytical toxicology: a review.
Journal of analytical toxicology 1997;21(2):116-26.
1997: H Hoja; Pierre Marquet; B Verneuil; H Lotfi; Jean-Louis Dupuy; B Pénicaut; Gérard Lachâtre
Determination of haloperidol and its reduced metabolite in human plasma by liquid chromatography-mass spectrometry with electrospray ionization.
Journal of chromatography. B, Biomedical sciences and applications 1997;688(2):275-80.
1997: Jean Debord; Jean-Pierre Charmes; Pierre Marquet; Louis Merle; Gérard Lachâtre
Population pharmacokinetics of amikacin in geriatric patients studied with the NPEM-2 algorithm.
International journal of clinical pharmacology and therapeutics 1997;35(1):24-7.
1996: Pierre Marquet; Bruno François; Philippe Vignon; Gérard Lachâtre
A soldier who had seizures after drinking quarter of a litre of wine.
Lancet 1996;348(9034):1070.
1996: Pierre Marquet; S Clément; H Lotfi; MF Dreyfuss; Jean Debord; D Dumont; Gérard Lachâtre
Analytical findings in a suicide involving sodium azide.
Journal of analytical toxicology 1996;20(2):134-8.
1996: H Lotfi; MF Dreyfuss; Pierre Marquet; Jean Debord; Louis Merle; Gérard Lachâtre
A screening procedure for the determination of 13 oral anticoagulants and rodenticides.
Journal of analytical toxicology 1996;20(2):93-100.
1996: Bruno François; D Cailloce; Pierre Marquet; V Billy; G Lachatre; R Gay
[Strychnine poisoning in rural areas. 73 cases].
Presse médicale (Paris, France : 1983) 1996;25(1):37.
1995: François DALMAY; M T Antonini; Pierre Marquet; R Menier
Acoustic properties of the normal chest.
The European respiratory journal 1995;8(10):1761-9.
1995: Christophe Sabot; Jean Debord; B Roullet; Pierre Marquet; Louis Merle; G Lachatre
Comparison of 2- and 3-compartment models for the Bayesian estimation of methotrexate pharmacokinetics.
International journal of clinical pharmacology and therapeutics 1995;33(3):164-9.
1995: Jean Debord; C Pessis; J C Voultoury; Pierre Marquet; H Lotfi; Louis Merle; Gérard Lachâtre
Population pharmacokinetics of amikacin in intensive care unit patients studied by NPEM algorithm.
Fundamental & clinical pharmacology 1995;9(1):57-61.
1995: Pierre Marquet
[Respiratory sounds].
Revue des maladies respiratoires 1995;12(2):87-101.
1992: A P Chassain; E Dauriac; P Blanc; M T Antonini; A Nicolas; P Villeneuve; Pierre Marquet; François DALMAY; M Valade
[Blood lactate in the steeplechase horse: triangular and rectangular series of steps during short duration races].
Archives internationales de physiologie, de biochimie et de biophysique 1992;100(5):369-74.
1992: Pierre Marquet; G Lachatre; Jean Debord; B Eichler; François Bonnaud; G Nicot
Pharmacokinetics of vinorelbine in man.
European journal of clinical pharmacology 1992;42(5):545-7.
1990: G Nicot; G Lachatre; Pierre Marquet; François Bonnaud; J P Vallette; J L Rocca
High-performance liquid chromatographic determination of navelbine in human plasma and urine.
Journal of chromatography 1990;528(1):258-66.